Sarepta Therapeutics (SRPT) PT Lowered to $203 at Barclays
Barclays analyst Gena Wang lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
